Study on Appropriate Technology of Standardized Diagnosis and Treatment for Diabetic Patients With Pulmonary Infections
NCT ID: NCT03617393
Last Updated: 2020-10-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
6000 participants
OBSERVATIONAL
2017-07-10
2021-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study on Diagnosis Value of mNGS Technology Among Diabetic Patients With Pulmonary Infections
NCT05552872
Metabolic Syndrome and Prediabetes
NCT07243821
A Study of Blood Metabolic Markers in Patients With Type 2 Diabetes Mellitus of Different Stages
NCT06155539
Prediction to Detect Pre-DM/DM in a Chinese Population
NCT05116319
Evaluation of Microcirculation of Peripheral Vascular Disease in Diabetes
NCT03528811
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pulmonary Infection with DM group
Patients with diabetes and pulmonary infection.
No interventions assigned to this group
Pulmonary Infection group
Patients with pulmonary infection while the fasting blood-glucose in the normal range.
No interventions assigned to this group
DM group
Patients without pulmonary infection while the fasting blood-glucose \> 8 mmol/L.
No interventions assigned to this group
Control group: normal people
Patients without pulmonary infection while the fasting blood-glucose in the normal range.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis through X-ray or CT: characteristic features of pulmonary infection
* Diagnosis through guideline of diabetes or history of diagnosed diabetes
* Age 40-70 years
Exclusion Criteria
* Withdraw from the study for any reason
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ruijin Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
ZHOU Min
Chief Physician of Department of Respiratory Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jieming QU, Ph.D., M.D.
Role: PRINCIPAL_INVESTIGATOR
China, Shanghai Ruijin Hospital Shanghai Jiao Tong University School of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ruijin Hospital Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017YFC1309700
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.